However, a wide range of more severe neurological disorders has been associated with TNF-α inhibitors, including Guillain–Barre syndrome, peripheral neuropathies, multiple sclerosis, optic neuritis and acute transverse myelitis [90,91]. Here, TNF is linked to multiple sclerosis.